Research Study Using an FDA Approved Topical Cream for the Treatment of Tinea Corporis (Ringworm)

What we are studying

This study is being done to see how well the drug Naftin® (naftifine hydrochloride) Cream, 2% works when the cream is applied once daily for 2 weeks to the areas of skin affected with ringworm. The results will be compared to those seen with a placebo cream (looks exactly like the study drug, but contains no active medicine)which has no active ingredient. Safety of the drug will also be measured.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 2 - 17

Eligibility Criteria

  • Presence of tinea corporis (ringworm)- confirmed by testing at the Screening visit; Cannot have tinea infection of the face
  • Scalp
  • Groin and/or feet; Cannot have uncontrolled diabetes; Cannot have evidence of other skin diseases such as psoriasis
  • Eczema
  • Etc.; Cannot have taken anti-fungals by mouth in the last 3 months

What is involved

  • 3 Visits; 2 Blood Draws; Questionnaire; Urine Pregnancy Test


If subject qualifies and completes all scheduled study visits they will be paid $75.00. If subjects are withdrawn or withdraw for any reason they will be paid $25.00 per completed visit.

Contact Information

Study Coordinator
Dermatology Clinical Studies

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.